title: Commentary: Collaboration between industry-based and academic epidemiologists.
authors.affiliation: Worldwide Epidemiology Department, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, USA. alice.d.white@gsk.com
authors.forename: A
authors.initials: A
authors.lastname: White
authors.forename: N
authors.initials: N
authors.lastname: Robinson
authors.forename: P
authors.initials: P
authors.lastname: Egger
authors.forename: M
authors.initials: M
authors.lastname: Stender
authors.forename: K
authors.initials: K
authors.lastname: Davis
authors.forename: J
authors.initials: J
authors.lastname: Weil
authors.forename: S
authors.initials: S
authors.lastname: Bowlin
mesh_terms: D000047:Academies and Institutes / Q000458:organization & administration*; D016265:Conflict of Interest; D004345:Drug Industry / Q000458:organization & administration*; D015340:Epidemiologic Research Design; D004813:Epidemiology / Q000941:ethics*; D004995:Ethics, Professional; D005260:Female; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D017749:Total Quality Management; D014481:United States